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Clinical experience for peripheral arterial disease treatment shows poor results when synthetic grafts
are used to approach infrapopliteal arterial segments. However, tissue engineering may be an option
to yield surrogate biocompatible neovessels. Thus, biological decellularized scaffolds could provide
natural tissue architecture to use in tissue engineering, when the absence of ideal autologous veins
reduces surgical options. The goal of this study was to evaluate different chemical induced
decellularization protocols of the inferior vena cava of rabbits. They were decellularized with Triton
X100 (TX100), sodium dodecyl sulfate (SDS) or sodium deoxycholate (DS). Afterwards, we assessed
the remaining extracellular matrix (ECM) integrity, residual toxicity and the biomechanical resistance
of the scaffolds. Our results showed that TX100 was not effective to remove the cells, while protocols
using SDS 1% for 2 h and DS 2% for 1 h, efﬁciently removed the cells and were better characterized.
These scaffolds preserved the original organization of ECM. In addition, the residual toxicity
assessment did not reveal statistically signiﬁcant changes while decellularized scaffolds retained
the equivalent biomechanical properties when compared with the control. Our results concludedniversity—UNESP, Botucatu Medical School, Department of Surgery and Orthopedics, Vascular
ião Júnior, 18618-970 Botucatu, SP, Brazil. Fax: þ55 1438801444.
(M. Bertanha).
E X P E R I M E N T A L C E L L R E S E A R C H 3 2 6 ( 2 0 1 4 ) 1 0 3 – 1 1 1104that protocols using SDS and DS were effective at obtaining decellularized scaffolds, which may be
useful for blood vessel tissue engineering.
& 2014 Published by Elsevier Inc.Introduction
Cardiovascular disease is the leading cause of death in Western
countries [1], associated with an increased incidence of peripheral
arterial disease (PAD) [2]. Clinical experience in PAD treatments
shows poor results when using synthetic grafts with a diameter
less than 6 mm. This is especially true when it is intended to treat
small caliber arteries such as those found in the lower limbs [3]
and that have thus beneﬁted from tissue engineering for the
development of blood vessels using both synthetic and biological
materials. The challenge of tissue engineering is to produce three
dimensional (3D) biocompatible scaffolds: structures that provide
seeded cells with a microenvironment mimicking natural in vivo
tissue architecture [4]. Given that the development of tissues and
organs using in vitro cellular engineering often suffers from a
shortage of donor tissue, (which limits the potential of obtaining
tissue engineered constructs), scaffolding technology is a promis-
ing approach to overcome these limitations [5,6].
Synthetic materials such as the commercially available polyglycolic
acid (PLG) and polylactic acid (PLA) may be used to obtain 3D tubular
structures, given that it presents some advantages; e.g., they do not
induce immunogenic reactions [7]. These PLG/PLA based scaffolds
were tested and proven efﬁcient in providing mechanical support,
good interaction with cells, and to have relative ease in handling.
However, scaffolds from these synthetic materials merely provide
three-dimensionality for cultured cells. They are artiﬁcially produced,
and do not possess a natural 3D architecture [7]. An alternative is to
use organs or tissues decellularized by different methods which does
not promote the immunogenic reaction of allogeneic tissue trans-
plants. Such methods have many advantages, such as the presence of
extracellular matrix (ECM) proteins, bioactivity, and natural 3D tissue
architecture [8].
A major concern around these bioengineered conduits for
clinical application is whether these 3D tubular structures sup-
port the various mechanical forces resulting from blood ﬂow, until
the implanted cells reach a natural level of ECM deposition that
allow for the development of natural tissue properties and,
therefore, mechanical resistance [9].
Herein, we focus on the use of three different detergents in 12
decellularization protocols in order to obtain a decellularized
blood vessel scaffold. Furthermore, the characterization of
remaining ECM composition, its potential toxic residual effects,
and its biomechanical properties were performed and analyzed.Methods
Animal housing conditions and tissue harvesting
Fifty nonpregnant female adult rabbits (New Zealand) were used
in all experiments. All procedures were conducted respecting the
Ethical Guidelines for Animal Experimentation, after the approvalby the Brazilian College for Animal Experimentation (COBEA
Process no. 711). All experiments followed the US National
Institutes of Health or European Commission guidelines. Rabbits
were housed under controlled conditions and fed a standard
pellet diet and water ad libitum, with the median age of animals
being 6 months with weight ranging between 2.5 and 3 kg.
Animals were anesthetized with tiletamine hydrochloride/zola-
zepam hydrochloride (20 mg/kg, i.m.) in association with 2%
xylazine chloridate (4 mg/kg, i.m.). The areas of tissue harvesting
were previously shaved and disinfected with water-soluble iodine
polyvinyl pyrrolidone solution. All following procedures were
conducted under aseptic conditions, and the animals were
euthanized using high doses of pentobarbital.
The infrarenal inferior vena cava was surgically removed and
their lumens washed off with sterile saline solution supplemen-
ted with unfractionated heparin (1000 UI/100 mL). These were
then stored at a sterile RPMI-1640 cell culture medium (Invitro-
gen™, Carlsbad, USA) supplemented with 100 U/mL penicillin,
100 mg/mL streptomycin, and 25 mg/mL amphotericin B (Invitro-
gen™) at 4 1C. Adipose tissue samples were surgically removed
from interscapular region, and immediately stored in RPMI cell
culture medium supplemented as described above.
Adipose derived mesenchymal stem cell culture
Adipose derived mesenchymal stem cells (ADMSCs) were obtained as
previously described through digestion with type I collagenase
(Invitrogen™) [10]. Cell culture procedures were performed with an
initial cell count of 2104 cells/cm2, obtained from ﬁve adipose tissue
fragments (different donors). These cells were seeded and expanded
in six-well culture plates (Techno Plastic Products™, Trasadingen,
Switzerland) using Dulbecco's modiﬁed Eagle's medium nutrient F12
mixture medium, supplemented with 10% fetal bovine serum (FBS),
100 U/mL penicillin, 100 mg/mL streptomycin, 25 mg/mL amphoter-
icin B (2 mmol/L L-glutamine; Invitrogen™), 1% (v/v) minimum
essential medium (MEM) essential amino acids solution (Invitro-
gen™), and 0.5% (v/v) of 10 mM MEM nonessential amino acids
solution (Invitrogen™). Upon reaching 80% conﬂuence, the mono-
layers were detached from culture wells with 0.25% trypsin/ethyle-
nediaminetetraacetic acid (Invitrogen™) and seeded at 75 cm2 culture
ﬂasks (Nunc™, Roskilde, Denmark). After two additional trypsin
exposures, cells were cryopreserved with ice-cold FBS supplemented
with 10% dimethyl sulfoxide and stored in liquid nitrogen [11].
Scaffold decellularization
Sodium dodecyl sulfate (SDS), sodium deoxycholate (DS), and
Triton X100 (TX100) were chosen as the decellularizing agents,
based on previous literature reports [12–17]. Working concentra-
tions were 1% and 2%, both during 1 h and 2 h of incubation
at 160 rpm at 37 1C in a shaker (News Brunswick Scientiﬁc™,
Nijmegen, The Netherlands). Following the decellularization of
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and stored in fresh PBS at 4 1C until further analysis.Histological processing and analysis of decellularization
efﬁciency
Decellularized vein fragments were ﬁxed in 10% buffered formalin
during 48 h. After washing ﬁve times in PBS, specimens were
dehydrated in a series of ethanol solutions and embedded in
parafﬁn. From these, 5 mM sections were obtained in a microtome,
and placed at microscopy slides. These slides were then stained
with hematoxilin and eosin (H&E) and mounted in Permouts
[18].
General morphology and absence of cells were examined by
H&E staining, with tests performed in triplicate. For morphologi-
cal assessment, 20 random ﬁelds at 400 magniﬁcation were
captured with a mounted-microscope camera and objectively
analyzed by investigating the total remaining cell nuclei/whole
cells and the ECM structure. To quantify the effectiveness in
removing cellular components, a scale was generated classifying
as optimal result the complete absence of or up to 3 nuclei.
Unsatisfactory results were classiﬁed as the presence of 4–50
nuclei, with unresponsive results being the presence of more than
50 nuclei. For the same 20 random ﬁelds, the ECM was visually
analyzed for its integrity. The absence of ECM disruption areas
was considered an optimum result; however the presence of one
or more areas of ECM disruption was considered an unsatisfactoryFig. 1 – Representative images of adipose derived mesenchymal stem
cell seeding, ADMSCs adhere strongly to the substrate and initiate
B) Alongside the adhered ADMSCs (arrowheads) some rounded-sha
culture vessel. These non-adherent cells are gradually removed from
week of cell culture, ADMSCs start to assemble into colonies (highl
through the culture vessel, resulting in high conﬂuence. D) Morph
nucleoli (arrowhead), ﬁbroblastic-shape (arrows) and many cytoplresult. Further analyses were performed only for the scaffolds in
which the decellularizing agents have proven efﬁcient for removal
of cells and maintenance of ECM network integrity.
Morphological analysis of decellularized scaffolds
Sequential slides were prepared for special histological protocols
by staining them with Picrosirius red, Masson's trichrome and
Calejja. In addition, slides were prepared for immunohistochemical
analysis of the collagen composition of decellularized scaffolds
using monoclonal antibodies against naturally occurring collagen
III and IV (Dako™, Glostrup, Denmark). This was done in order to
establish the integrity of collagen content. All morphological
analyses allowed for comparison of the histological pattern after
each treatment with the control veins [19,20]. Picrossirius stained
slides were analyzed under a polarized light microscope to assess
compaction and maturity of collagen ﬁbers [21]. For each analysis,
3 blood vessels were employed.
Biomechanical characterization
Decellularized vein fragments were stretched longitudinally until
failure for evaluation of mechanical properties. The extremities of
each segment were ﬁxed to the smooth plates of non-cutting
metal clamps of a universal machine for mechanical studies using
EMICs, model DL 10.000 (Equipments and Testing Systems™, Ltd.
Curitiba, PR, Brazil). This machine offers a precision of aroundcells (ADMSCs) under cell culture (n¼5). A) Following 48 h of
mitosis, leading to partial conﬂuence of the culture vessel.
ped cells (arrows), mainly lymphocytes, are also present on the
the cultures, through culture medium exchange. C) After one
ighted in black). These colonies will reach out to other colonies
ological features of ADMSCs, such as well deﬁned nucleus and
asmatic projections (asterisk). Scale bars¼50 μm.
Fig. 2 – Representative sections of all rabbit vein fragments
(n¼42), either control (vehicle) blood vessels or blood vessels
submitted to different detergent decellularization agents,
stained by hematoxylin and eosin (n¼3 for each treatment).
The image shows that the vessels' histoarchitecture (mainly
the extracellular matrix structure) was apparently preserved at
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puter using Mtests 1.00 software. The velocity chosen for tension
application was 30 mm/min [22,23]. At the end of the test, the
software provided a load-elongation diagram and the results of
yield point (N), stiffness coefﬁcient (N/mm) and failure load (N).
The yield point was obtained by Johnson's method and indicates
the maximum load value at which a material still retains the
capacity to return to its original length when the load is removed.
On the graph it corresponds to the maximum tension value of a
linear function within the load–deformation curve (elastic phase)
[24]. The stiffness coefﬁcient is obtained by dividing the force
applied (N) by the deformation produced (mm) and therefore
measures the stiffness of the structure [25]. Thus, stiffness is the
linear and constant numeric relation between load and elongation
at the yield point [26]. The failure load, or maximum load, is the
greatest load withstood by either material before breaking, i.e.,
the tensile strength. For all measurements, 13 fragments of each
decellularized scaffolds were compared to 13 control veins.
Toxic residual effects of decellularized scaffolds
To verify whether decellularized scaffolds are suitable for in vitro
applications, their potential toxic residual effects were investi-
gated. Therefore, we conducted an additional experiment in
which 1106 expanded ADMSCs were thawed, seeded in ultra-
low attachment 6-well culture plates, cultured for 24 h,
and exposed to decellularized vein scaffolds. Cells were main-
tained in culture for 48 h. Following exposure, the scaffolds were
scrapped off to release any adhering cells. Cell viability was
analyzed using a Neubauer chamber after trypan blue staining.
Moreover, remaining cells were used to observe the presence of
apoptosis by ﬂow cytometry using antibody anti-caspase 3 [27].
The BD Pharmingen™ PE Active Caspase-3 Apoptosis Kits was
used and protocols were performed according to the manufac-
turers' recommendations. Brieﬂy, the cells were removed from
the wells, centrifugated, and incubated with BD Cytoﬁx/Cyto-
perm™ ﬁxation/permeabilization solution for 15 min at room
temperature. Cells were then washed with Perm/Wash™ Buffer
and a further incubation step was performed with 20 μL of
monoclonal antibody against the active form of caspase-3 in the
presence of 100 μL of permeabilization solution for 45 min in
dark. Subsequently, cells were analyzed by ﬂow cytometry using
the BD FACSCalibur™ equipment and the software Cell Quest™.
This experiment was performed in triplicate with the controls
having the same amount of cells in the absence of the scaffolds.the end of the decellularization process in all treatments.
However, the complete absence of nuclei or cellular residues
was obtained only when sodium deoxycholate (DS) and
sodium dodecyl sulfate (SDS) were employed. Triton does not
efﬁciently remove cell nuclei under the current experimental
conditions. Scale bars¼50 μm.Results
Adipose derived mesenchymal stem cell culture
Following the initial seeding, cells actively adhered to the bottom
of the cell culture ﬂasks (Fig. 1A). A few cells were observed
in suspension, typically leukocytes derived from the vascular
portion of the processed adipose tissue (Fig. 1B); these cells were
gradually removed during the replacement of the culture med-
ium. In 2 days, adherent cells started to assemble into colonies
(Fig. 1C), showing previously described morphologic characteris-
tics of MSCs, such as ﬁbroblastic-shape, well deﬁned nucleus, and
presence of cytoplasmic projections (Fig. 1D) [11].Scaffold decellularization
Aproximately 42 vein fragments were obtained, decellularized and
employed for all characterization assays, as described above. Regard-
less of the agent used for decellularization, scaffolds acquired some
common macroscopic characteristics, such as pronounced opacity
and slight elongation. The general structure of all 42 vein fragments
was preserved (Fig. 2).
Table 1 – For the morphological assessment, 20 random
ﬁelds (combined from 3 different sections of each vehicle
or decellularized vein) at 400 magniﬁcation were cap-
tured at a mounted-microscope camera and objectively
analyzed by investigating the total remaining cell nuclei/
whole cells and the ECM structure. To quantify the effec-
tiveness in removing cellular components, a scale was
created, adopting as optimal result: the complete absence
or up to 3 cells, an unsatisfactory result: the presence of 4–
50 cells, and an unresponsive result: the presence of more
than 50 cells.
Analysis of decellularizing efﬁciency
Treatment r3 cells 4–50 cells Z51 cells
Vehicle 0 6/20 (30%) 14/20 (70%)
Triton 1%—1 h 0 6/20 (30%) 14/20 (70%)
Triton 1%—2 h 0 16/20 (80%) 4/20 (20%)
Triton 2%—1 h 0 14/20 (70%) 6/20 (30%)
Triton 2%—2 h 0 18/20 (90%) 2/20 (10%)
DS 1%—1 h 16/20 (80%) 4/20 (20%) 0
DS 1%—2 h 20/20 (100%) 0 0
DS 2%—1 h 20/20 (100%) 0 0
DS 2%—2 h 20/20 (100%) 0 0
SDS 1%—1 h 16/20 (80%) 4/20 (20%) 0
SDS 1%—2 h 20/20 (100%) 0 0
SDS 2%—1 h 20/20 (100%) 0 0
SDS 2%—2 h 20/20 (100%) 0 0
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efﬁciency
The decellularization with Triton X-100 protocol was not efﬁcient
for cell removal. Multiple nuclei were consistently observed under
microscopy analysis (Fig. 2). Triton X-100 was thus considered a
poor decelularizing agent (presence of many cells, and some areas
of ECM disruption were observed).
Both decellularization protocol using SDS and DS, at a concen-
tration of 1% for 1 h, showed that there was not a complete
decellularization of the scaffolds (20% containing between 4 and
50 cells), as evidenced by incomplete absence of nuclei, while
maintaining the ECM structure intact (absence of areas of ECM
disruption) (Fig. 2). However, when these detergents were used at
a concentration of 1% for 2 h, a total removal of cell nuclei was
observed, while still maintaining the structure of the ECM (100%
containing between 0 and 3 cells), and absence of areas of ECM
disruption (Fig. 2). SDS and DS at 2% during 1 h of exposure
completely removed all cells (100% containing between 0 and 3
cells) while maintaining an intact ECM structure (absence of areas
of ECM disruption). Higher concentrations of SDS or DS at 2% and
with a higher exposure time of 2 h resulted in efﬁcient removal of
all cells, but led to a high degree of ECM disruption (100%
containing between 0 and 3 cells) (Fig. 2). However, while many
areas of ECM disruption were observed, they were considered
unsatisfactory decellularized agents (data not shown).
Among all tested protocols, DS at 2% for 1 h and SDS at 1% for
2 h exposure led to more efﬁcient decellularization results, with
complete cell removal while preserving ECM network architec-
ture. Table 1 summarizes these ﬁndings. Further characterization
assays were thus performed for these protocols only (DS at 2% for
1 h and SDS at 1% for 2 h).Morphological analysis of decellularized scaffolds
For a more complete investigation of the post-decellularization
ECM architecture, a complementary analysis with Sirius red,
Masson's trichrome and Calejja staining was performed. The
results strengthened our ﬁndings, highlighting that the ECM of
the scaffolds that have been decellularized with DS and SDS have
good maintenance of integrity, with emphasis in the apparent
maintenance of elastic and collagen ﬁbers (Fig. 3). Immunohisto-
chemical analyses showed that type III collagen content was
slightly reduced (Fig. 3), and type IV collagen content was further
decreased compared to type III collagen (Fig. 3).
Polarized light assessment of collagen ﬁbers showed that
almost 100% of ﬁbers were stained in red, which indicates that
these ﬁbers are compact and mature (Fig. 4). Moreover, neither
detergent signiﬁcantly inﬂuenced collagen organization on the
scaffolds, when compared to controls.
Biomechanical characterization
Decellularized scaffolds produced using SDS, DS, and control veins
(n¼13) were longitudinally stretched to failure for the evaluation
of mechanical properties. Test results were interpreted as the load
elongation diagram, results of the yield point (N), the coefﬁcient
of stiffness (N/mm), and failure load (N) values. Results showed a
large variability (standard deviation) amongst decellularized
scaffolds as well control scaffolds (when inside groups were
compared), which can be explained by ﬁssures on the vessels as
well as fragility caused by the sectioning of lumbar tributary vein.
There were no statistically signiﬁcant differences between the
three groups for all tested parameters. However, slightly reduced
(non-signiﬁcant) elasticity and rigidity of the decellularized veins,
(compared to controls), were observed (Table 2).
Toxic residual effects of decellularized scaffolds
Both employed assays (Trypan blue and caspase-3) did not result in
statistically signiﬁcant differences among control veins and decel-
lularized veins for their viability or apoptosis of cells exposed to
scaffolds (Table 3). The exception was the DS which showed viability
signiﬁcantly superior to the other experiments (Table 3).Discussion
Autologous transplantation (AT) still remains the main form of
treatment for PAD; however AT is not always possible and the
remaining treatment alternative is the use of synthetic materials
whose longevity is less known [28]. Tissue engineering is a
promising alternative for the production of tissues and organs,
especially when there is a lack of appropriate donor tissues,
aiming at providing biocompatible grafts to replace damaged,
unfunctional organs or tissues [29–31].
Over the years, biotechnology-derived techniques have boosted
the development of numerous scaffolds which may be artiﬁcially
constructed or derived from natural compounds. Most synthetic
scaffolds are produced with polyglycolic acid (PGA) and its
variants, such as polyglycolic acid-poly-L-lactic acid (PGAPLLA),
among others [7,25,32]. Scaffolds derived from these materials
can be produced in a controlled way, in different shapes,
and with different porosity coefﬁcients. However, synthetic
Fig. 3 – Representative sections of rabbit control (vehicle) blood vessels and blood vessels submitted to different detergent
decellularization agents, stained with H&E (for general histology), picrossirius (collagen stains in red), Masson's trichrome
(collagen stains in blue), calleja (elastic ﬁbers stains in dark blue/black), combined Masson's and calleja (collagen stains in blue,
elastic ﬁbers in dark blue/black), and sections probed with anti-collagen III and IV after immunohistochemistry (n¼3 for each
analysis). Generally, all decellularization agents preserved the extracellular matrix structure of the blood vessels in comparison to
vehicle (control) vessels. This can be veriﬁed as the red, blue, and dark blue colors are present at decellularized vessels (in sections
stained with picrossirius, Masson's trichrome, and calleja, respectively). Type III collagen content was slightly reduced by the
treatments, and type IV collagen reduced after the decellularization processes. Scale bars¼500 μm.
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inﬂammatory, display higher immunogenic reactions, possess
toxic degradation, and may induce ﬁbrosis, leaﬂet retraction,
and early stenosis [8]. In addition, previous reports show thatbiodegradable polyglactin–PGA used to produce vascular scaffolds
is unstable and causes aneurysm formation [33].
While these artiﬁcial products are widely employed and
characterized, little effort has been put on the use of natural
Fig. 4 – Representative sections of rabbit control (vehicle) blood vessels and blood vessels submitted to DS 2% and SDS 1%
decellularization agents, stained with picrossirius, under light (left column) and polarized (right column) microscopy (n¼3 for
each analysis). The image shows that the vessels' collagen content, stained in red with picrossirius, (on the left column), was
characterized mainly as compact old collagen ﬁbers, stained in dark red, as seen in the right column, under the polarized light.
Apparently, sodium deoxycholate (DS) and sodium dodecyl sulfate (SDS), at these concentrations, are able to preserve the collagen
architecture. This resembles the collagen architecture of the vehicle (control) vessels. Scale bars¼500 μm.
E X P E R I M E N T A L C E L L R E S E A R C H 3 2 6 ( 2 0 1 4 ) 1 0 3 – 11 1 109biological compounds as the main source of scaffold. Biological
scaffolds may circumvent the hurdles of synthetic scaffolds,
as they are much more cell-compatible, such as the compo-
nents of the ECM: collagen, elastin, ﬁbronectin, hyaluronic acid,
glycosaminoglycans (GAGs), and others, which beneﬁts from
their bioactive, biocompatible, and similar mechanical properties
compared to in vivo tissues [8,33,34]. One approach to obtain
biological 3D scaffolds is to employ the original tissue where the
cell cultures shall be seeded in the moment of transplantation. To
this purpose, however, in a heterologous approach, these scaffolds
need to be decellularized to prevent immune rejections. Previous
reports suggest that scaffolds derived from decellularized tissues
have a facilitating role in the differentiation and obtainment of the
expected tissue, as they contain the bioactive molecules and ligands
necessary for stem cell maturation and diffusion of nutrients, as well
as the naturally occurring 3D tissue architecture [11,33].
Given that the most commonly used tissue graft substitute for
cardiovascular surgery in humans is the great saphenous vein, it
seemed logical to study, initially in animal models, the behavior of
decellularized veins, given that it is feasible to set up banks of
decellularized veins from cadaveric donors, aiming at, in thefuture, the customization of blood vessel production. In this
report, we have chosen the infrarenal inferior vena cava, due to
similarities such as diameter, thickness, and histological structure
to the great saphenous vein in humans [35].
We ﬁrst demonstrated that the production of decellularized veins
was feasible, depending on the detergent selected for this purpose.
While Triton X100 does not completely remove cell nuclei, SDS and
DS are more efﬁcient for decellularization, being also able to preserve
ECM matrix architecture. Interestingly, other authors have reported
successful decellularization using Triton X100; however, not only
were they decellularizing other tissues, but they also employed
different concentrations and time of exposure that could account for
the discrepancies observed in the efﬁcacy of cell removal by Triton
X100 [4,35,36]. Given that for heterologous usage these veins must
be cell-free, and Triton X100 did not completely remove cell nuclei,
this detergent cannot be used to produce blood vessel scaffolds for
therapeutic purposes and was removed early from our study.
Even though cell removal is a key point in the process of
decelularization for scaffold production, it also is important that
the remaining ECM structure is maintained. Previous reports have
shown that ECM components such as collagen, elastin, ﬁbronectin,
Table 2 – Biomechanical characterization of vehicle (control) and decellularized blood vessels. Biomechanical analysis of vehicle
treated and decellularized blood vessels. Data are expressed as mean7standard deviation (SD) (n¼13). After statistical analysis
(described in “Materials and Methods”) no signiﬁcant values were observed when all treatments were compared to control
vessels, meaning that DS and SDS are able to preserve the scaffold's biomechanical properties.
Biomechanical parameters Treatments
Vehicle DS SDS
Yield point (N) 2.27570.709 1.89070.562 2.07370.894
Stiffness coefﬁcient (N/mm) 0.68370.237 0.49370.190 0.61370.270
Failure load (N) 2.54070.735 2.16470.612 2.25570.872
Mean7SD. All obtained results were non-signiﬁcant.
Table 3 – Toxic residual effects of decellularized scaffolds. Data is expressed as mean7standard deviation (SD). After statistical
analysis (described in “Materials and Methods”) only a signiﬁcant value was observed, when DS treatment was compared to
control vessels, however, with higher viability. In this sense, the data shows that the scaffolds do not have signiﬁcant toxic
residual effects, as observed by the high viability and low positive counts for caspase 3 cells. Experiments were carried out in
triplicate.
Parameters Treatments
Vehicle DS SDS
Apoptosis—trypan blue (% live cells) 74.933712.219 88.13374.502n 83.76771.563
Apoptosis—caspase 3 (% positive cells) 0.88370.329 1.25070.581 1.56771.266
Mean7SD.
n Statistically signiﬁcant difference with po0.05 in comparison with vehicle treated vessels.
E X P E R I M E N T A L C E L L R E S E A R C H 3 2 6 ( 2 0 1 4 ) 1 0 3 – 1 1 1110vitronectin, and laminin are responsible for cell adhesion, prolifera-
tion, differentiation, and thus maintaining the structure of the vessel
[37]. Herein, scaffolds obtained by the two best protocols for cell
removal were further analyzed for ECM composition.
In the second step, we demonstrated that the adjacent con-
nective tissue content was fairly preserved after decellularization
with SDS and DS, with special emphasis for elastin and type-I
collagen (results also obtained and reported for other tissues)
[8,35]. For a better understanding of the remaining collagen
content on these decelularized scaffolds, we performed immuno-
histochemistry for type-III collagen, which was well preserved after
treatment. However, we also performed the same technique for
type-IV collagen, which was slightly decreased in both treatments
compared with the controls. This ﬁnding raised a concern about
the mechanical stability of the decellularized scaffolds and
prompted us to move to the next phase of investigation [35].
In a third step, the biomechanical tensile experiments showed
no signiﬁcant statistical differences with the control blood vessels
(p40.05), demonstrating that the strength of the scaffolds,
produced with SDS and DS, is very similar to the veins that did
not undergo decelularization. This leads to the conclusion that the
scaffolds maintain their natural mechanical tensile resistance
after the decellularization process, mainly because the elastin
and collagen (type I and III) content are preserved. Other
mechanical properties were investigated through yield point,
stiffness, and failure load testing, which also were similar to
non-decellularized blood vessels (p40.05). Other authors per-
formed similar experiments with aorta or aortic segment of other
animals with similar results [35,38].
Having demonstrated that SDS and DS are efﬁcient at removing
cells, preserving the ECM proteins, and preserving the desiredbiomechanical properties, we ﬁnally investigated whether these
agents had residual toxicity in the produced scaffolds that could
subsequently impair their use in cell culture. We showed that
toxicity was not observed when stem cell cultures were exposed
to these scaffolds, as there was no decrease in viability of living cells,
as observed by Tripan blue dye. To conﬁrm this ﬁnding, new cultures
were exposed to these scaffolds, probed with anti-caspase 3
antibodies, and analyzed using ﬂow cytometry. The results con-
ﬁrmed the previous ﬁndings that SDS and DS do not induce
signiﬁcant toxicity; therefore it is likely safe to use these detergents,
at the optimal concentration and time of exposure demonstrated
herein, as a base of decelularization for tissue engineering.Conclusion
The methods of decellularization of blood vessels, in rabbits, can
be performed efﬁciently while maintaining ECM architecture with
two different protocols tested: 1% SDS for 2 h or 2% DS for 1 h
of exposure. Decelularized scaffolds were mechanically tested
to evaluate their strength and stiffness and proved surprisingly
similar with control veins, indicating that they are resistant
enough to be tested in vivo. Moreover, there was no residual
toxicity of these scaffolds as observed in stem cell cultures. In this
sense, these techniques may be suitable for tissue engineering of
blood vessels for future clinical use.Conﬂict of interest statement
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